From Lab to Market: Tracking Today’s Shifting Pathways for Biotech
Published: | Updated:
Outlining the key touchpoints for embracing change and opportunity in the “messy, tough—and fun” R&D-to-commercial transition journey.
Carlos Martin
Advertisement
Strategic Advisor, Rocket Pharmaceuticals
Articles by Carlos Martin
Advertisement
Latest Updated Articles
From Lab to Market: Tracking Today’s Shifting Pathways for BiotechPublished: September 17th 2025 | Updated: September 24th 2025
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
Leading in the Psychedelic Space: Q&A with Tarek Rabah
5